Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05091047 · ClinicalTrials.gov registry record · NA
Effect of the Erchonia® EVRL OTC™ for the Relief of Diabetic Peripheral Neuropathy Foot Pain
A NA study, sponsored by Erchonia Corporation.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT05091047 is a NA study that has completed, run by Erchonia Corporation. The registered enrollment target is 9 participants.
The verdict
NCT05091047, a NA study, has completed, sponsored by Erchonia Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This study is to see if applying red and violet low-level laser light can help to reduce foot pain associated with diabetic peripheral neuropathy,
Interventions
- DEVICE Erchonia EVRL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2021-06-16 |
| Est. Completion | 2021-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05091047
The ClinicalTrials.gov registry entry for NCT05091047 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Erchonia Corporation, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Erchonia EVRL is the first listed.
NCT05091047 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05091047 about?
NCT05091047 is a clinical study titled "Effect of the Erchonia® EVRL OTC™ for the Relief of Diabetic Peripheral Neuropathy Foot Pain". This study is to see if applying red and violet low-level laser light can help to reduce foot pain associated with diabetic peripheral neuropathy,
What is the current status of trial NCT05091047?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2021-06-16. Estimated completion is 2021-12-01.
What interventions are being tested in trial NCT05091047?
The interventions under investigation include: Erchonia EVRL (DEVICE).
Who is sponsoring clinical trial NCT05091047?
This trial is sponsored by Erchonia Corporation, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.